115113-94-5

Basic information

• Product Name: (2S,3R,4E,8E,2'R)-3-O-(tert-butyldiphenylsilyl)-N-(2'-hydroxyhexadecanoyl)-1-O-(tetra-O-acetyl-β-D-glucopyranosyl)-4,8-sphingadienine
• Synonyms: (2S,3R,4E,8E,2'R)-3-O-(tert-butyldiphenylsilyl)-N-(2'-hydroxyhexadecanoyl)-1-O-(tetra-O-acetyl-β-D-glucopyranosyl)-4,8-sphingadienine
• CAS NO: 115113-94-5
• Molecular Weight: 1120.59
• Mol File: 115113-94-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (2S,3R,4E,8E,2'R)-3-O-(tert-butyldiphenylsilyl)-N-(2'-hydroxyhexadecanoyl)-1-O-(tetra-O-acetyl-β-D-glucopyranosyl)-4,8-sphingadienine(CAS DataBase Reference)
• NIST Chemistry Reference: (2S,3R,4E,8E,2'R)-3-O-(tert-butyldiphenylsilyl)-N-(2'-hydroxyhexadecanoyl)-1-O-(tetra-O-acetyl-β-D-glucopyranosyl)-4,8-sphingadienine(115113-94-5)
• EPA Substance Registry System: (2S,3R,4E,8E,2'R)-3-O-(tert-butyldiphenylsilyl)-N-(2'-hydroxyhexadecanoyl)-1-O-(tetra-O-acetyl-β-D-glucopyranosyl)-4,8-sphingadienine(115113-94-5)

Safety Data

• Hazardous Substances Data: 115113-94-5(Hazardous Substances Data)

Upstream product

• 115018-46-7 (2S,3R,4E,8E,2'R)-3-O-(tert-butyldiphenylsilyl)-N-(2'-hydroxyhexadecanoyl)-4,8-sphingadienine 
• 572-09-8 2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl bromide 
• 115018-44-5 (2S,3R,4E,8E,2'R)-2-(2'-acetoxyhexadecanoyl)amino-1-O-benzoyl-4,8-octadiene-1,3-diol 
• 115031-70-4 1-O-benzoylsphingadiene hydrochloride 
• 115018-42-3 (4S,1'R,2'E,6'E)-4,5-dihydro-4-(1'-hydroxy-2',6'-hexadecadienyl)-2-phenyl-1,3-oxazole 
• 115018-45-6 (2S,3R,4E,8E,2'R)-N-(2'-Acetoxyhexadecanoyl)-1-O-benzoyl-3-O-(tert-butyldiphenylsilyl)-4,8-sphingadienine 
• 88195-82-8 p-nitrophenyl 2-O-acetyl-(2R)-2-hydroxypalmitate 

Downstream Products

• 114297-20-0 (2′R)-N-{(1S,2R,3E,7E)-1-[(β-D-glucopyranosyloxy)methyl]-2-hydroxyheptadeca-3,7-dien-1-yl}-2-hydroxyhexadecanamide 

Relevant articles and documents

Synthesis of Sphingosine Relatives, VII. - Synthesis fo Anti-Ulcerogenic Cerebrosides Isolated from Tetragonia tetragonoides

The synthesis of (2S,3R,4E,8E,2'R)-1-O-(β-D-glucopyranosyl)-N-(2'-hydroxyhexadecanoyl)-4,8-sphingadienine (1a) and its (8Z) isomer (1b) was accomplished by employing (R)-2-aminohexadecanoic acid, D-glucose, and (S)-serine as chiral sources.